BioSante Pharmaceuticals Inc (NASDAQ:BPAX)
| 1.15 Data as of May 23 |  +0.01 / +0.88%Today’s Change | 1.01 Today|||52-Week Range 3.45 | -6.50% Year-to-Date |
Latest BPAX News | Press Releases
No recent news for BioSante Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.14 |
| Today’s open | 1.13 |
| Day’s range | -- - -- |
| Volume | 111,977 |
| Average volume (3 months) | 179,895 |
| Market cap | $27.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +59.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +428.71% |
| P/E ratio | NM |
| Price/Sales | 11.63 |
| Price/Book | 0.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRNMVerenium Corp | +0.04 | +1.83% |
| RPBIFResponse Biomedical ... | 0.00 | 0.00% |
| GOGCGlobal Green Inc | -0.00 | -6.98% |
| ROSGRosetta Genomics Ltd | +0.05 | +1.27% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $2.3M |
| Annual profit (last year) | -$27.7M |
| Net profit margin | -1,204.73% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Vice Chairman, President & Chief Executive Officer Stephen M. Simes, MBA |
Vice President- Operations William D. Milling, CPA |
Corporate headquarters Lincolnshire, Illinois |
Forecasts
